169 related articles for article (PubMed ID: 24671790)
1. Multicenter evaluation of the Quidel Lyra Direct C. difficile nucleic acid amplification assay.
Beck ET; Buchan BW; Riebe KM; Alkins BR; Pancholi P; Granato PA; Ledeboer NA
J Clin Microbiol; 2014 Jun; 52(6):1998-2002. PubMed ID: 24671790
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.
Deak E; Miller SA; Humphries RM
J Clin Microbiol; 2014 Mar; 52(3):960-3. PubMed ID: 24352999
[TBL] [Abstract][Full Text] [Related]
3. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay.
Carroll KC; Buchan BW; Tan S; Stamper PD; Riebe KM; Pancholi P; Kelly C; Rao A; Fader R; Cavagnolo R; Watson W; Goering RV; Trevino EA; Weissfeld AS; Ledeboer NA
J Clin Microbiol; 2013 Dec; 51(12):4120-5. PubMed ID: 24088862
[TBL] [Abstract][Full Text] [Related]
4. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays.
Pancholi P; Kelly C; Raczkowski M; Balada-Llasat JM
J Clin Microbiol; 2012 Apr; 50(4):1331-5. PubMed ID: 22278839
[TBL] [Abstract][Full Text] [Related]
5. Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.
Stellrecht KA; Espino AA; Maceira VP; Nattanmai SM; Butt SA; Wroblewski D; Hannett GE; Musser KA
J Clin Microbiol; 2014 May; 52(5):1423-8. PubMed ID: 24554744
[TBL] [Abstract][Full Text] [Related]
6. Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samples.
Elfassy A; Kalina WV; French R; Nguyen H; Tan C; Sebastian S; Wilcox MH; Davies K; Kutzler MA; Jansen KU; Anderson A; Pride MW
Anaerobe; 2021 Oct; 71():102415. PubMed ID: 34298152
[TBL] [Abstract][Full Text] [Related]
7. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.
Boyanton BL; Sural P; Loomis CR; Pesta C; Gonzalez-Krellwitz L; Robinson-Dunn B; Riska P
J Clin Microbiol; 2012 Mar; 50(3):640-5. PubMed ID: 22189114
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing Clostridioides difficile infections with molecular diagnostics: multicenter evaluation of revogene C. difficile assay.
Sambri V; Gateau C; Zannoli S; Dirani G; Couturier J; Op den Buijs I; Roymans R; Hallet E; Arnold M; Zumoberhaus A; Steiner S; van de Bovenkamp J; Altwegg M; Berlinger L; Barbut F;
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1169-1175. PubMed ID: 32062723
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections.
Lalande V; Barrault L; Wadel S; Eckert C; Petit JC; Barbut F
J Clin Microbiol; 2011 Jul; 49(7):2714-6. PubMed ID: 21525213
[TBL] [Abstract][Full Text] [Related]
10. Molecular test based on isothermal helicase-dependent amplification for detection of the Clostridium difficile toxin A gene.
Eckert C; Holscher E; Petit A; Lalande V; Barbut F
J Clin Microbiol; 2014 Jul; 52(7):2386-9. PubMed ID: 24759714
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.
Landry ML; Ferguson D; Topal J
J Clin Microbiol; 2014 Jan; 52(1):275-80. PubMed ID: 24226924
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.
Peterson LR; Young SA; Davis TE; Wang ZX; Duncan J; Noutsios C; Liesenfeld O; Osiecki JC; Lewinski MA
J Clin Microbiol; 2017 Dec; 55(12):3426-3436. PubMed ID: 28954901
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the illumigene C. difficile assay for toxigenic Clostridium difficile detection: a prospective study of 302 consecutive clinical fecal samples.
Hong G; Park KS; Ki CS; Lee NY
Diagn Microbiol Infect Dis; 2014 Nov; 80(3):177-80. PubMed ID: 25241189
[TBL] [Abstract][Full Text] [Related]
14. A Multicenter Study of the Revogene C. difficile System for Detection of the Toxin B Gene from Unformed Stool Specimens.
Mashock MJ; Faron ML; Carroll KC; Dang C; Lewis S; Salimnia H; Lephart P; Loo VG; Schmitt BH; Young S; Buchan BW; Ledeboer NA
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776191
[No Abstract] [Full Text] [Related]
15. Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens.
Buchan BW; Mackey TL; Daly JA; Alger G; Denys GA; Peterson LR; Kehl SC; Ledeboer NA
J Clin Microbiol; 2012 Dec; 50(12):3932-6. PubMed ID: 23015667
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
[TBL] [Abstract][Full Text] [Related]
18. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
Humphries RM; Uslan DZ; Rubin Z
J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples.
Stamper PD; Alcabasa R; Aird D; Babiker W; Wehrlin J; Ikpeama I; Carroll KC
J Clin Microbiol; 2009 Feb; 47(2):373-8. PubMed ID: 19073875
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of loop-mediated isothermal amplification assay for detection of Clostridioides difficile infection: A prospective diagnostic performance study.
Girão ES; Vásconez Noguera SL; Sanchez Espinoza EP; Pereira Alves Madeira Bezerra CL; Lino FM; Côrtes MF; Alves Dos Santos S; Paranhos-Baccala G; Perdigão Neto LV; Costa SF
Anaerobe; 2021 Oct; 71():102410. PubMed ID: 34174401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
